Tag: Allergan

Allergan is a multi-national pharmaceutical that produces branded and generic drugs, and performs pharmaceutical research and development. Formerly known as Actavis.

Allergan and Sosei breaked trials of Alzheimer’s drug

Sosei (Japan) and Allergan (USA) have been forced to call a halt to testing of a drug for Alzheimer’s disease and other forms of dementia after cancer was seen in non-human primate studies. The dru...

Allergan acquires neurotoxin biotech Bonti

Allergan announced it has agreed to acquire Bonti, a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs.

Allergan and Editas Medicine keep up their work on CRISPR genome editing drug

Allergan and Editas Medicine announced that Allergan's wholly-owned subsidiary has exercised its option to develop and commercialize EDIT-101 globally for the treatment of LCA10.

Biosimilar ABP 980 obtained a positive opinion from CHMP

cancer treatment
Amgen and Allergan have announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for the marketing authorisation of ABP 980, a biosimilar to Herceptin®.

Teva will receive $700 million from Allergan

Allergan PLC, headquartered in Dublin, Ireland, a global pharmaceutical company, will pay Teva Pharmaceutical Industries Ltd. $700 million to dismiss a dispute between the two companies

Allergan will buy Zeltiq Aesthetics for $2.48 billion

Botox maker Allergan agreed to pay $2.48 billion in cash for Zeltiq Aesthetics Inc, adding a system that it says helps people slim down by freezing fat away to the company's line-up of aesthetic produ...